We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsLeafly PicksCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Leafly Picks
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
  • Help
  1. Home
  2. News
  3. Politics
  4. Massachusetts Names Legalization Advocate Shaleen Title to Commission
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
Politics

Massachusetts Names Legalization Advocate Shaleen Title to Commission

Leafly StaffLast updated July 28, 2020
Financial District of Boston, Massachusetts viewed from Boston Harbor.

The final members of the Massachusetts Cannabis Control Commission were named today, filling out the five-member panel just before today’s deadline.

One of the appointments may come as a pleasant surprise to those in the advocacy community. Shaleen Title, co-founder of the THC Staffing Group and a co-author of the state’s legalization measure, was named to the seat intended to focus on legal, policy, and social justice issues related to the regulated industry.

The other members named today were Britte McBride, a public service lawyer who was appointed to the commission by Attorney General Maura Healey; and Kay Doyle, an attorney for the Massachusetts Department of Public Health.

The previously announced appointees are outgoing State Sen. Jennifer Flanagan and business executive Steven Hoffman. Flanagan, Hoffman, and McBride opposed last year’s legalization measure. Title supported it (she helped write it), and Doyle’s opinion on the measure is unknown.

Title: Bolsters panel’s policy chops and industry knowledge.

Title comes into the job as the commissioner with the most knowledge of the legal industry around the nation. She’s known for her advocacy work to bring more women and people of color into both the drug policy reform movement and the emerging legal cannabis industry. Title has also served as a board member for Students for Sensible Drug Policy, where she helped create and fund a diversity scholarship program. In 2012, she served as a senior staffer on the campaign for Amendment 64, Colorado’s historic adult-use legalization measure.

In recent years she’s served as a partner, with Danielle Schumacher, in the cannabis industry recruiting firm THC Staffing, which connects employers with candidates from diverse backgrounds and a variety of industries. On that topic, Title has been interviewed by Leafly and contributed advice to those entering the industry.

The five-member commission will act as an independent state agency established to regulate and oversee the state’s new adult-use cannabis program, which is expected to open in 2018. The Cannabis Control Commission will receive advice from the 25-member Cannabis Advisory Board, whose members are also appointed by the governor, attorney general, and treasurer.

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
massachusetts
Leafly Staff
Leafly Staff
Leafly is the world’s largest cannabis information resource, empowering people in legal cannabis markets to learn about the right products for their lifestyle and wellness needs. Our team of cannabis professionals collectively share years of experience in all corners of the market, from growing and retail, to science and medicine, to data and technology.
View Leafly Staff's articles

The latest in Politics

  • Cannabis rescheduling just sped up: What you need to know about the executive order image
    Cannabis rescheduling just sped up: What you need to know about the executive order
    Morgan Rosendale
  • How US import tariffs are impacting cannabis prices and products image
    How US import tariffs are impacting cannabis prices and products
    Leafly Staff
  • Ohioans must activate to defend cannabis freedoms from lawmakers image
    Ohioans must activate to defend cannabis freedoms from lawmakers
    David Downs
  • Montanans must activate to protect legalization in 2025 image
    Montanans must activate to protect legalization in 2025
    David Downs
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.